These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 5469691)

  • 1. [Hepatic clearance and urinary excretion of rifamycin in patients with or without liver diseases].
    Rodriguez Garay EA; Laudano OM; Spetale Mdel R
    Farmaco Prat; 1970 Jul; 25(7):423-7. PubMed ID: 5469691
    [No Abstract]   [Full Text] [Related]  

  • 2. Rifamycin SV (Rifocin 500) clearance as a hepatic function test.
    Laudano OM; Brasca A
    Farmaco Prat; 1974 Jun; 29(6):347-50. PubMed ID: 4840110
    [No Abstract]   [Full Text] [Related]  

  • 3. [Metabolism of rifampicin. I. Biliary and urinary excretion in normal rats and with experimental liver injury].
    Rodriguez Garay EA; Spetale MR; Morisoli LS; Rassero JA
    Farmaco Prat; 1973; 28(9):481-8. PubMed ID: 4751984
    [No Abstract]   [Full Text] [Related]  

  • 4. [Absorption, distribution, metabolism and excretion of rifampicin (3-(4-methyl-1-piperazinyl-iminomethyl) rifamycin SV) in the rat].
    Akimoto T; Ono K; Nanpo T
    Jpn J Antibiot; 1970 Jun; 23(3):250-6. PubMed ID: 5312377
    [No Abstract]   [Full Text] [Related]  

  • 5. [Rifampicin and its clinical use].
    Fafrowicz B
    Wiad Lek; 1971 Jul; 24(3):233-8. PubMed ID: 4926926
    [No Abstract]   [Full Text] [Related]  

  • 6. The Australian rifampicin trial.
    Proust AJ
    Med J Aust; 1971 Jul; 2(2):85-94. PubMed ID: 4999365
    [No Abstract]   [Full Text] [Related]  

  • 7. Half-life of rifampicin after repeated administration of different doses in humans.
    Curci G; Bergamini N; Delli Veneri F; Ninni A; Nitti V
    Chemotherapy; 1972; 17(6):373-81. PubMed ID: 5082603
    [No Abstract]   [Full Text] [Related]  

  • 8. Rifamycin SV clearance as hepatic functional test. Comparison with the bromsulphalein clearance.
    Laudano OM; Cifarelli C; Brasca A; Mercol E
    Rev Int Hepatol; 1967; 17(5):423-8. PubMed ID: 6056143
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on distribution of dimethylhydrazone of 3-formyl rifamycin SV, a new antibiotic substance.
    Schiatti P; Maffii G
    Chemotherapy; 1967; 12(4):234-46. PubMed ID: 6065357
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum and urine concentrations of rifampicin administered by intravenous infusion in man.
    Acocella G; Bonollo L; Mainardi M; Margaroli P; Tenconi LT
    Arzneimittelforschung; 1977; 27(6):1221-6. PubMed ID: 578447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rifampicin: a new rifamycin. 3. Absorption, distribution, and elimination in man.
    Furesz S; Scotti R; Pallanza R; Mapelli E
    Arzneimittelforschung; 1967 May; 17(5):534-7. PubMed ID: 5631581
    [No Abstract]   [Full Text] [Related]  

  • 12. [Rifamide and rifamycin SV: some comparative observations on kinetics in man].
    Acocella G; Pallanza R; Santilli E; Nicolis FB
    Antibiotica; 1966 Mar; 4(1):17-48. PubMed ID: 5960847
    [No Abstract]   [Full Text] [Related]  

  • 13. [Several supplementary investigations on rifampicin (rifamycin AMP)].
    Kitamoto O; Fukaya K; Tomori G; Suzuki T
    Jpn J Antibiot; 1970 Jun; 23(3):273-5. PubMed ID: 5312212
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of liver function tests as predictors of rifampicin metabolism in cirrhosis.
    McConnell JB; Powell-Jackson PR; Davis M; Williams R
    Q J Med; 1981; 50(197):77-82. PubMed ID: 7267969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution, excretion and toxicity of rifazine, a new semisynthetic rifamycin.
    Schiatti P; Dezulian VM; Serralunga MG; Maffii G
    Chemotherapy; 1967; 12(4):247-60. PubMed ID: 6065358
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of chronic drug-resistant pulmonary tuberculosis with rifampin and ethambutol.
    Jeanes CW; Jessamine AG; Eidus L
    Can Med Assoc J; 1972 Apr; 106(8):884-8. PubMed ID: 4623743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local diffusibility of rifampicin in tuberculous lesions of bone and joint.
    Popescu E; Algeorge G; Paunescu E; Stoinescu M; Rudescu D
    Respiration; 1971; 28():Suppl:44-51. PubMed ID: 5150795
    [No Abstract]   [Full Text] [Related]  

  • 18. [Rifampicin levels in blood, urine and kidney tissue in patients with renal tuberculosis].
    Mochalova TP; Kanevskaia SS; Danilova NK
    Antibiotiki; 1973 Feb; 18(2):178-80. PubMed ID: 4776397
    [No Abstract]   [Full Text] [Related]  

  • 19. [How to evaluate hepatic function: pharmacokinetic approach].
    Malè PJ
    Rev Med Suisse Romande; 1985 Apr; 105(4):313-6. PubMed ID: 4012141
    [No Abstract]   [Full Text] [Related]  

  • 20. The hepatic galactose elimination capacity measured after a single intravenous injection of galactose in normal adults and in patients with various liver diseases.
    den Blaauwen DH; Thijs LG
    Neth J Med; 1973; 16(1):2-13. PubMed ID: 4696952
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.